Skip to main content
SBFM
NASDAQ Life Sciences

Sunshine Registers 31.1M Series B Warrant Shares at $2.7674 Strike

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.41
Mkt Cap
$1.985M
52W Low
$2.41
52W High
$464
52W Position info
0.0% above low
Off High info
99% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SBFM is trading near its 52-week low of $2.41 (0.0% above the low) on light trading volume (0.1× avg).

Summary

Sunshine Biopharma filed an S-1 to register 31,087,198 shares issuable on exercise of its Series B Warrants, currently struck at $2.7674. No shares were sold; full cash exercise would raise about $31 million, but the warrants carry a ratchet that lowers the strike if stock is sold below it.


Key Events · Financing and Capital Events · SBFM

  • S-1 Registers 31.1M Warrant Shares

    The registration covers 31,087,198 shares issuable on exercise of Series B Warrants, estimated on an assumed adjusted exercise price of $1.00; 11,233,359 Series B Warrants are currently outstanding.

  • Cash Exercise Would Raise ~$31M

    At the current $2.7674 exercise price, full cash exercise would produce gross proceeds of about $31 million (31,087,198 x $1.00 = $31,087,198 per the fee table; the prospectus states approximately $31 million net). The filing states there is no assurance any warrants will be exercised.

  • Warrant Ratchet Can Lower Strike

    If Sunshine issues or agrees to sell stock below the then-current exercise price, that price resets to the lower figure and the share count is adjusted upward so aggregate exercise proceeds stay unchanged — a discounted raise would enlarge the overhang.

  • Nasdaq Listing Pressure Disclosed

    The company says it does not currently meet the proposed $5 million Market Value of Listed Securities requirement and remains subject to immediate delisting notice on any 30-day bid price shortfall until October 2027, following the 1-for-20 reverse split effective October 26, 2026.


Analysis · SBFM · Life Sciences

This is a registration statement, not a sale: no shares have been issued and no cash has been received. Its purpose is to put a resale/exercise shelf in place so the 11,233,359 outstanding Series B Warrants can only be exercised for cash rather than through the cashless formula. Were every warrant exercised at the current $2.7674 strike, gross proceeds would be about $31 million — roughly double the $14.6 million cash the company reported at September 30 — though the filing itself says there is no assurance any warrants will be exercised. The real risk sits in the ratchet: if Sunshine sells stock below the then-current exercise price, that price resets lower and the share count rises proportionately, so a future discounted raise could expand this overhang well beyond the 31.1 million shares registered here. With the stock trading at $2.41, near its 52-week low, and the company already failing the proposed $5 million market value listing test, the practical read is more potential supply overhanging a thinly valued equity.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SBFM was trading at $2.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2M. The 52-week trading range was $2.41 to $464.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SBFM - Latest Insights

SBFM
Nov 12, 2026, 11:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.38 info
Change: -$0.3224 (-12%) info
Market Cap: $1.985M info
SBFM
Nov 12, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $2.38 info
Change: -$0.4324 (-15%) info
Market Cap: $1.985M info
SBFM
Nov 12, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $2.38 info
Change: -$0.4224 (-15%) info
Market Cap: $1.985M info
SBFM
Oct 22, 2026, 9:25 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1638
Real-time Price: $2.38 info
Change: Reverse Stock Split info
Market Cap: $1.985M info
SBFM
Oct 14, 2026, 5:21 PM EDT
Filing Type: PRE 14C
Importance Score:
8
Price at Filing: $0.232
Real-time Price: $2.38 info
Change: Reverse Stock Split info
Market Cap: $1.985M info